Enovis Corp

NYSE:ENOV   4:00:00 PM EDT
40.22
+1.50 (+3.87%)
6:22:53 PM EDT: $40.42 +0.20 (+0.50%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.33B
Current PEN/A
Forward PE 14.84
2yr Forward PE 12.85
See more stats
Estimates Current Quarter
Revenue$504.65 Million
Adjusted EPS$0.62
See more estimates
10-Day MA$40.24
50-Day MA$42.97
200-Day MA$51.42
See more pivots

Enovis Corp Stock, NYSE:ENOV

2711 Centerville Road, Suite 400, Wilmington, Delaware 19808
United States of America
Phone: +1.302.252.9160
Number of Employees: 6550

Description

Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.